Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients

Francesca Collina, Margherita Cerrone, Valentina Peluso, Michelino de Laurentiis, Roberta Caputo, Rossella De Cecio, Giuseppina Liguori, Gerardo Botti, Monica Cantile, Maurizio Di Bonito

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Developing of personalized therapies for Triple Negative Breast Cancer (TNBC) requires a more detailed knowledge of its biology and a correct stratification of molecular subtypes. Androgen Receptor (AR) is expressed in a large part of TNBCs but its prognostic role in this Breast Cancer (BC) subtype is highly debated. In this study, we analyzed AR expression in a series of 238 TNBCs and correlated its expression with clinical-pathological features, survival, and metabolic profile. We showed a consistent association between AR expression and a better prognosis of TNBC patients, while its downregulation appeared strongly associated with diabetic disease. Since a recent prospective study reported a lower BC risk in diabetic women treated with drugs able to reduce circulating levels of glucose compared with non-diabetic woman, and in vitro studies showed that AR level are regulated directly by hyperglycemia, we speculate on the perspective of new integrated therapies for TNBC.

Original languageEnglish
Pages (from-to)3530-3539
Number of pages10
JournalAmerican Journal of Translational Research
Volume8
Issue number8
Publication statusPublished - 2016

Fingerprint

Triple Negative Breast Neoplasms
Androgen Receptors
Medical problems
Down-Regulation
Breast Neoplasms
Metabolome
Hyperglycemia
Prospective Studies
Glucose
Survival
Therapeutics
Pharmaceutical Preparations

Keywords

  • Androgen receptor
  • Diabetes
  • Triple negative breast cancers

ASJC Scopus subject areas

  • Medicine(all)
  • Cancer Research
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients. / Collina, Francesca; Cerrone, Margherita; Peluso, Valentina; de Laurentiis, Michelino; Caputo, Roberta; De Cecio, Rossella; Liguori, Giuseppina; Botti, Gerardo; Cantile, Monica; Di Bonito, Maurizio.

In: American Journal of Translational Research, Vol. 8, No. 8, 2016, p. 3530-3539.

Research output: Contribution to journalArticle

Collina, Francesca ; Cerrone, Margherita ; Peluso, Valentina ; de Laurentiis, Michelino ; Caputo, Roberta ; De Cecio, Rossella ; Liguori, Giuseppina ; Botti, Gerardo ; Cantile, Monica ; Di Bonito, Maurizio. / Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients. In: American Journal of Translational Research. 2016 ; Vol. 8, No. 8. pp. 3530-3539.
@article{31cd47914f84448f9300c1f8d4b29966,
title = "Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients",
abstract = "Developing of personalized therapies for Triple Negative Breast Cancer (TNBC) requires a more detailed knowledge of its biology and a correct stratification of molecular subtypes. Androgen Receptor (AR) is expressed in a large part of TNBCs but its prognostic role in this Breast Cancer (BC) subtype is highly debated. In this study, we analyzed AR expression in a series of 238 TNBCs and correlated its expression with clinical-pathological features, survival, and metabolic profile. We showed a consistent association between AR expression and a better prognosis of TNBC patients, while its downregulation appeared strongly associated with diabetic disease. Since a recent prospective study reported a lower BC risk in diabetic women treated with drugs able to reduce circulating levels of glucose compared with non-diabetic woman, and in vitro studies showed that AR level are regulated directly by hyperglycemia, we speculate on the perspective of new integrated therapies for TNBC.",
keywords = "Androgen receptor, Diabetes, Triple negative breast cancers",
author = "Francesca Collina and Margherita Cerrone and Valentina Peluso and {de Laurentiis}, Michelino and Roberta Caputo and {De Cecio}, Rossella and Giuseppina Liguori and Gerardo Botti and Monica Cantile and {Di Bonito}, Maurizio",
year = "2016",
language = "English",
volume = "8",
pages = "3530--3539",
journal = "American Journal of Translational Research",
issn = "1943-8141",
publisher = "e-Century Publishing Corporation",
number = "8",

}

TY - JOUR

T1 - Downregulation of androgen receptor is strongly associated with diabetes in triple negative breast cancer patients

AU - Collina, Francesca

AU - Cerrone, Margherita

AU - Peluso, Valentina

AU - de Laurentiis, Michelino

AU - Caputo, Roberta

AU - De Cecio, Rossella

AU - Liguori, Giuseppina

AU - Botti, Gerardo

AU - Cantile, Monica

AU - Di Bonito, Maurizio

PY - 2016

Y1 - 2016

N2 - Developing of personalized therapies for Triple Negative Breast Cancer (TNBC) requires a more detailed knowledge of its biology and a correct stratification of molecular subtypes. Androgen Receptor (AR) is expressed in a large part of TNBCs but its prognostic role in this Breast Cancer (BC) subtype is highly debated. In this study, we analyzed AR expression in a series of 238 TNBCs and correlated its expression with clinical-pathological features, survival, and metabolic profile. We showed a consistent association between AR expression and a better prognosis of TNBC patients, while its downregulation appeared strongly associated with diabetic disease. Since a recent prospective study reported a lower BC risk in diabetic women treated with drugs able to reduce circulating levels of glucose compared with non-diabetic woman, and in vitro studies showed that AR level are regulated directly by hyperglycemia, we speculate on the perspective of new integrated therapies for TNBC.

AB - Developing of personalized therapies for Triple Negative Breast Cancer (TNBC) requires a more detailed knowledge of its biology and a correct stratification of molecular subtypes. Androgen Receptor (AR) is expressed in a large part of TNBCs but its prognostic role in this Breast Cancer (BC) subtype is highly debated. In this study, we analyzed AR expression in a series of 238 TNBCs and correlated its expression with clinical-pathological features, survival, and metabolic profile. We showed a consistent association between AR expression and a better prognosis of TNBC patients, while its downregulation appeared strongly associated with diabetic disease. Since a recent prospective study reported a lower BC risk in diabetic women treated with drugs able to reduce circulating levels of glucose compared with non-diabetic woman, and in vitro studies showed that AR level are regulated directly by hyperglycemia, we speculate on the perspective of new integrated therapies for TNBC.

KW - Androgen receptor

KW - Diabetes

KW - Triple negative breast cancers

UR - http://www.scopus.com/inward/record.url?scp=84983249677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983249677&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84983249677

VL - 8

SP - 3530

EP - 3539

JO - American Journal of Translational Research

JF - American Journal of Translational Research

SN - 1943-8141

IS - 8

ER -